Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Bladder Cancer

Free Subscription Articles published in Eur Urol Retrieve available abstracts of 129 articles: HTML format Text format

Single Articles

January 2012
1. NASELLI A , Introini C, Timossi L, Spina B, et al
   A Randomized Prospective Trial to Assess the Impact of Transurethral Resection in Narrow Band Imaging Modality on Non-Muscle-Invasive Bladder Cancer Recurrence.
   Eur Urol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. KANDIMALLA R , van Tilborg AA, Kompier LC, Stumpel DJ, et al
   Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers.
   Eur Urol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. BURGER M , Otto W, Hartmann A
   Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378-84.
   Eur Urol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
4. VAN RHIJN BW , van der Kwast TH, Jewett MA, Zlotta AR, et al
   Reply to Maximilian Burger, Wolfgang Otto, and Arndt Hartmann's Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:
   Eur Urol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
5. BANERJEE S , Kumar V
   Re: Sven van den Bosch, J. Alfred Witjes. Long-term Cancer-specific Survival in Patients with High-risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review. Eur Urol 2011;60:493-500.
   Eur Urol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
6. SIMONATO A , Ennas M
   Re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta, et al. The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer with Special Emphasis on Cancer Control and Complications. Eur Urol 2011;60:767-75.
   Eur Urol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
7. CHALLACOMBE B , Dasgupta P
   Reply to Alchiede Simonato and Marco Ennas' Letter to the Editor re: Ben J. Challacombe, Bernard H. Bochner, Prokar Dasgupta, et al. The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer with Special Empha
   Eur Urol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
8. MAURER T , Souvatzoglou M, Kubler H, Opercan K, et al
   Diagnostic Efficacy of [11C]Choline Positron Emission Tomography/Computed Tomography Compared With Conventional Computed Tomography in Lymph Node Staging of Patients With Bladder Cancer Prior to Radical Cystectomy.
   Eur Urol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. ROSENBLATT R , Sherif A, Rintala E, Wahlqvist R, et al
   Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer.
   Eur Urol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. MEIJER RP , van Rhijn BW
    A Plea for Long-Term Surveillance in Bacillus Calmette-Guerin-Treated Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
11. PALOU J , Rodriguez Faba O, Pena JA
    Reply from Authors re: J. Alfred Witjes. Prognosis of T1G3 Bladder Cancer: How Well Can We Predict Progression? Eur Urol. In press. DOI:10.1016/j.eururo.2011.11.001.
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    November 2011
12. EFSTATHIOU JA , Spiegel DY, Shipley WU, Heney NM, et al
    Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. WITJES JA
    Prognosis of T1G3 Bladder Cancer: How Well Can We Predict Progression?
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
14. VAN RHIJN BW , van der Kwast TH, Alkhateeb SS, Fleshner NE, et al
    A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. PALOU J , Sylvester RJ, Rodriguez Faba O, Parada R, et al
    Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guerin.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. SHARIAT SF , Ehdaie B, Rink M, Cha EK, et al
    Clinical Nodal Staging Scores for Bladder Cancer: A Proposal for Preoperative Risk Assessment.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. ZUIVERLOON TC , Nieuweboer AJ, Vekony H, Kirkels WJ, et al
    Markers Predicting Response to Bacillus Calmette-Guerin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. POUESSEL D , Culine S, Mongiat-Artus P
    Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial.
    Eur Urol. 2011;60:870-1.
    PubMed     Text format     Related articles   
    
    
    
    
19. ROSCIGNO M , Brausi M, Heidenreich A, Lotan Y, et al
    Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.
    Eur Urol. 2011;60:776-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. BOORJIAN SA
    Postoperative intravesical therapy to prevent bladder tumor recurrence: are we ready to listen yet?
    Eur Urol. 2011;60:711-2.
    PubMed     Text format     Related articles   
    
    
    
    
21. O'BRIEN T , Ray E, Singh R, Coker B, et al
    Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).
    Eur Urol. 2011;60:703-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
22. GIANNARINI G , Petralia G, Thoeny HC
    Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging: A Critical Analysis of the Literature.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. SUNDAR S
    Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-Invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009-18.
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
24. STENZL A
    Reply to Alberto Bossi's Letter to the Editor re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009-18.
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. BOSSI A
    Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009-18.
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
26. CHA EK , Tirsar LA, Schwentner C, Christos PJ, et al
    Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. CHROMECKI TF , Cha EK, Shariat SF
    Stage pT0 after radical cystectomy: are all patients equal?
    Eur Urol. 2011;60:603-4.
    PubMed     Text format     Related articles   
    
    
    
    
28. FUNG B , Kessler TM, Haeni K, Burkhard FC, et al
    Bowel function remains subjectively unchanged after ileal resection for construction of continent ileal reservoirs.
    Eur Urol. 2011;60:585-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
29. SCHMITZ-DRAGER BJ
    Identifying Risk Factors in Patients With Non-Muscle-Invasive Bladder Cancer: Clinical Implications.
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
30. ZHANG H , Ye D
    Re: Hassan Abol-Enein, Derya Tilki, Ahmed Mosbah, et al. Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study. Eur Urol 2011;60:572-7.
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
31. LAMMERS RJ , Witjes WP, Hendricksen K, Caris CT, et al
    Smoking Status Is a Risk Factor for Recurrence After Transurethral Resection of Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. FERNANDEZ-GOMEZ J
    Reply from Authors re: Richard J. Sylvester. How Well Can You Actually Predict Which Non-Muscle-Invasive Bladder Cancer Patients Will Progress? Eur Urol. In press. doi:10.1016/j.eururo.2011.06.001.
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
33. OLIVEIRA CA , Rodriguez O, Palou J, Palou-Redorta J, et al
    Re: Amit R. Patel, Edmund S. Sabanegh, J. Stephen Jones, et al. Bacillus Calmette-Guerin osteomyelitis mimicking spinal metastasis from urothelial cell carcinoma of the bladder. Eur Urol 2010;58:934-7.
    Eur Urol. 2011;60:e7.
    PubMed     Text format     Related articles   
    
    
    
    
34. GUDJONSSON S
    Re: Willem Oosterlinck,Richard Sylvester, Marco Babjuk, et al. Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors? Eur Urol 2011;59:374-6.
    Eur Urol. 2011;60:e2-3.
    PubMed     Text format     Related articles   
    
    
    
    
35. AGUNDEZ M , Grau L, Palou J, Algaba F, et al
    Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guerin response in patients with T1G3 high-risk bladder tumours.
    Eur Urol. 2011;60:131-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. OOI WL , Stockler M, Hayne D
    Re: Willem Oosterlinck, Ziya Kirkali,Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guerin and with bacillus Calmette-Guerin alone in patients with carcinoma in situ of the urinary bladder:
    Eur Urol. 2011;60:e1.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
37. TILKI D , Burger M, Dalbagni G, Grossman HB, et al
    Urine Markers for Detection and Surveillance of Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. ABOL-ENEIN H , Tilki D, Mosbah A, El-Baz M, et al
    Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. SYLVESTER RJ
    How Well Can You Actually Predict Which Non-Muscle-Invasive Bladder Cancer Patients Will Progress?
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
40. VAN DEN BOSCH S , Alfred Witjes J
    Long-term Cancer-specific Survival in Patients with High-risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. BABJUK M , Oosterlinck W, Sylvester R, Kaasinen E, et al
    EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.
    Eur Urol. 2011;59:997-1008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
42. FERNANDEZ-GOMEZ J , Madero R, Solsona E, Unda M, et al
    The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin: External Validation of the EORTC Risk Tables.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. FLEISCHMANN A , Rotzer D, Seiler R, Studer UE, et al
    Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. VAN DER HORST G , van Asten JJ, Figdor A, van den Hoogen C, et al
    Real-Time Cancer Cell Tracking by Bioluminescence in a Preclinical Model of Human Bladder Cancer Growth and Metastasis.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. CHALLACOMBE BJ , Bochner BH, Dasgupta P, Gill I, et al
    The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer With Special Emphasis on Cancer Control and Complications.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. GOOSSENS-LAAN CA , Gooiker GA, van Gijn W, Post PN, et al
    A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate.
    Eur Urol. 2011;59:775-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. CATTO JW , Alcaraz A, Bjartell AS, De Vere White R, et al
    MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
    Eur Urol. 2011;59:671-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
48. CATTO JW
    Thirty-Five Years of Intravesical Bacillus Calmette-Guerin for Bladder Cancer: Where Now?
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
49. LAMMERS RJ , Witjes JA, Inman BA, Leibovitch I, et al
    The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
50. HERR HW , Dalbagni G, Donat SM
    Bacillus Calmette-Guerin Without Maintenance Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. JENTZMIK F , Schrader AJ, Schrader M
    Re: Beat Roth, Frederic D. Birkhauser, Pascal Zehnder, et al. Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a p
    Eur Urol. 2011;59:e17-8.
    PubMed     Text format     Related articles   
    
    
    
    
52. ZHU Y , Ye D
    Re: Beat Roth, Frederic D. Birkhauser, Pascal Zehnder, et al. Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a p
    Eur Urol. 2011;59:e15.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
53. ZLOTTA AR , Roumeguere T, Kuk C, Alkhateeb S, et al
    Select Screening in a Specific High-Risk Population of Patients Suggests a Stage Migration Toward Detection of Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. STENZL A , Cowan NC, De Santis M, Kuczyk MA, et al
    Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. OOSTERLINCK W , Sylvester R, Babjuk M, Kaasinen E, et al
    Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors?
    Eur Urol. 2011;59:374-6.
    PubMed     Text format     Related articles   
    
    
    
    
56. OOSTERLINCK W , Kirkali Z, Sylvester R, da Silva FC, et al
    Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guerin and with bacillus Calmette-Guerin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 tri
    Eur Urol. 2011;59:438-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
57. CATTO JW
    Improving the Outcome for Invasive Bladder Cancer: The Debate Regarding Pelvic Lymphadenectomy Moves From If to How.
    Eur Urol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
58. JENSEN JB , Munksgaard PP, Sorensen CM, Fristrup N, et al
    High Expression of Karyopherin-alpha2 Defines Poor Prognosis in Non-Muscle-Invasive Bladder Cancer and in Patients with Invasive Bladder Cancer Undergoing Radical Cystectomy.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. HERR HW
    Re: use of radical cystectomy for patients with invasive bladder cancer.
    Eur Urol. 2011;59:301.
    PubMed     Text format     Related articles   
    
    
    
    
60. RAMPERSAUD EN JR , Belldegrun AS
    Re: Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance.
    Eur Urol. 2011;59:301-2.
    PubMed     Text format     Related articles   
    
    
    
    
61. HORENBLAS S
    Re: variations in treatment policies and outcome for bladder cancer in the Netherlands.
    Eur Urol. 2011;59:300.
    PubMed     Text format     Related articles   
    
    
    
    
62. NOVARA G , Ficarra V, Zattoni F
    Is robot-assisted radical cystectomy the right way to reduce complications in patients undergoing radical cystectomy?
    Eur Urol. 2011;59:219-21.
    PubMed     Text format     Related articles   
    
    
    
    
63. HAYN MH , Hellenthal NJ, Hussain A, Stegemann AP, et al
    Defining morbidity of robot-assisted radical cystectomy using a standardized reporting methodology.
    Eur Urol. 2011;59:213-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. MAFFEZZINI M
    For wider acceptance of radical cystectomy and extended pelvic lymphadenectomy.
    Eur Urol. 2011;59:211-2.
    PubMed     Text format     Related articles   
    
    
    
    
65. ROTH B , Birkhauser FD, Zehnder P, Burkhard FC, et al
    Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trial.
    Eur Urol. 2011;59:204-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
66. MAY M , Herrmann E, Bolenz C, Tiemann A, et al
    Lymph Node Density Affects Cancer-Specific Survival in Patients with Lymph Node-Positive Urothelial Bladder Cancer Following Radical Cystectomy.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. FEIFER AH , Taylor JM, Tarin TV, Herr HW, et al
    Maximizing Cure for Muscle-Invasive Bladder Cancer: Integration of Surgery and Chemotherapy.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
68. DEGRAFF DJ , Clark PE
    Detection of Tumor Cells in the Bone Offers Independent Prognostic Value in Bladder Cancer Patients: The Clinical and Basic Science Perspective.
    Eur Urol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
69. RETZ M , Rotering J, Nawroth R, Buchner A, et al
    Long-term Follow-up of Bladder Cancer Patients with Disseminated Tumour Cells in Bone Marrow.
    Eur Urol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. CHIONG E , Kesavan A, Mahendran R, Chan YH, et al
    NRAMP1 and hGPX1 Gene Polymorphism and Response to Bacillus Calmette-Guerin Therapy for Bladder Cancer.
    Eur Urol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. ZLOTTA AR
    Re: a sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.
    Eur Urol. 2010;58:943-4.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
72. GAUTAM G , Steinberg GD
    Re: impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.
    Eur Urol. 2010;58:794.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
73. SHAPIRO A , Gofrit ON, Pizov G, Cohen JK, et al
    Raman Molecular Imaging: A Novel Spectroscopic Technique for Diagnosis of Bladder Cancer in Urine Specimens.
    Eur Urol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. MARGEL D , Pesvner-Fischer M, Baniel J, Yossepowitch O, et al
    Stress Proteins and Cytokines are Urinary Biomarkers for Diagnosis and Staging of Bladder Cancer.
    Eur Urol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. GIANNARINI G , Kessler TM, Thoeny HC, Nguyen DP, et al
    Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution?
    Eur Urol. 2010;58:486-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
76. HAYN MH , Hussain A, Mansour AM, Andrews PE, et al
    Reply from authors re: Urs E. Studer, Laurence Collette. Robot-assisted cystectomy: does it meet expectations? Eur Urol 2010;58:203-4.
    Eur Urol. 2010;58:204-6.
    PubMed     Text format     Related articles   
    
    
    
    
77. STUDER UE , Collette L
    Robot-assisted cystectomy: does it meet expectations?
    Eur Urol. 2010;58:203-4.
    PubMed     Text format     Related articles   
    
    
    
    
78. HAYN MH , Hussain A, Mansour AM, Andrews PE, et al
    The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
    Eur Urol. 2010;58:197-202.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. BABJUK M
    Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives.
    Eur Urol. 2010;58:191-2.
    PubMed     Text format     Related articles   
    
    
    
    
80. DIVRIK RT , Sahin AF, Yildirim U, Altok M, et al
    Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial.
    Eur Urol. 2010;58:185-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. PAPATSORIS AG , Mitsogiannis I, Deliveliotis C
    Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9.
    Eur Urol. 2010;58:e19.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
82. MALMSTROM PU
    Re: Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance.
    Eur Urol. 2010;58:178.
    PubMed     Text format     Related articles   
    
    
    
    
83. YORUKOGLU K , Tuna B, Kirkali Z
    Re: Matthias May, Sabine Brookman-Amissah, Jan Roigas, et al. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. Eur Ur
    Eur Urol. 2010;58:e7.
    PubMed     Text format     Related articles   
    
    
    
    
84. PONHOLZER A , Madersbacher S
    Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9.
    Eur Urol. 2010;58:e9.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
85. COLOMBO R
    Invasive Bladder Cancer and the Role of Follow-up: Should We Consider the Match Over at Radical Cystectomy or Should We Play for Extra Time?
    Eur Urol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
86. HUANG J , Lin T, Liu H, Xu K, et al
    Laparoscopic Radical Cystectomy with Orthotopic Ileal Neobladder for Bladder Cancer: Oncologic Results of 171 Cases With a Median 3-Year Follow-up.
    Eur Urol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. VAN RHIJN BW , Zuiverloon TC, Vis AN, Radvanyi F, et al
    Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. ALDEMIR M , Canda AE, Balbay MD
    Re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive B
    Eur Urol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
89. MALMSTROM PU , Sylvester R
    Reply to Mustafa Aldemir and Abdullah Erdem Canda's Letter to the Editor re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesi
    Eur Urol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
90. LOTAN Y
    Words of wisdom. Re: randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance.
    Eur Urol. 2010;57:1116-7.
    PubMed     Text format     Related articles   
    
    
    
    
91. MAFFEZZINI M
    Words of Wisdom. Re: urinary diversion and morbidity after radical cystectomy for bladder cancer.
    Eur Urol. 2010;57:1116.
    PubMed     Text format     Related articles   
    
    
    
    
92. BARTON GROSSMAN H
    Words of wisdom. Re: reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guerin.
    Eur Urol. 2010;57:1115.
    PubMed     Text format     Related articles   
    
    
    
    
93. CAI T , Luciani LG, Malossini G
    Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guerin, and bacillus Cal
    Eur Urol. 2010;57:e57.
    PubMed     Text format     Related articles   
    
    
    
    
94. NOVARA G , Ficarra V, Minja A, De Marco V, et al
    Functional results following vescica ileale Padovana (VIP) neobladder: midterm follow-up analysis with validated questionnaires.
    Eur Urol. 2010;57:1045-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. LI WM , Shen JT, Li CC, Ke HL, et al
    Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma.
    Eur Urol. 2010;57:963-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. PRUTHI RS , Nix J, McRackan D, Hickerson A, et al
    Robotic-assisted laparoscopic intracorporeal urinary diversion.
    Eur Urol. 2010;57:1013-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. RAMANI VA , Maddineni SB, Grey BR, Clarke NW, et al
    Differential complication rates following radical cystectomy in the irradiated and nonirradiated pelvis.
    Eur Urol. 2010;57:1058-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
98. KASSOUF W , Hautmann RE, Bochner BH, Lerner SP, et al
    A Critical Analysis of Orthotopic Bladder Substitutes in Adult Patients with Bladder Cancer: Is There a Perfect Solution?
    Eur Urol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. DIVRIK RT , Sahin AF, Ergor G
    Reply from Authors re: Giacomo Novara, Vincenzo Ficarra. Does Routine Second Transurethral Resection Affect the Long-Term Outcome of Patients with T1 Bladder Cancer? Why a Flawed Randomized Controlled Trial Cannot Address the Issue. Eur Urol. In press
    Eur Urol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
100. BABJUK M
     New insights in intravesical treatment for intermediate- and high-risk non-muscle-invasive urothelial bladder carcinoma.
     Eur Urol. 2010;57:774-6.
     PubMed     Text format     Related articles   
     
     
     
     
101. SYLVESTER RJ , Brausi MA, Kirkels WJ, Hoeltl W, et al
     Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guerin, and bacillus Calmette-Guerin plus isoniazid in patients with intermediate- and high-r
     Eur Urol. 2010;57:766-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. DALBAGNI G
     Editorial comment on: detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.
     Eur Urol. 2010;57:849.
     PubMed     Text format     Related articles   
     
     
     
     
103. MARIAPPAN P , Zachou A, Grigor KM
     Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.
     Eur Urol. 2010;57:843-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. BURGER M
     Editorial comment on: prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications.
     Eur Urol. 2010;57:858.
     PubMed     Text format     Related articles   
     
     
     
     
105. MAY M , Brookman-Amissah S, Roigas J, Hartmann A, et al
     Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications.
     Eur Urol. 2010;57:850-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
106. HERR HW
     Re: Derya Tilki, Oliver Reich, Pierre I. Karakiewicz, et al. Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome. Eur Urol. In press. doi 10.1016/j.eururo.2010.01.015.
     Eur Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
107. NOVARA G , Ficarra V
     Does Routine Second Transurethral Resection Affect the Long-Term Outcome of Patients with T1 Bladder Cancer? Why a Flawed Randomized Controlled Trial Cannot Address the Issue.
     Eur Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
108. COLOMBO R
     Words of wisdom. Re: treatment of non-muscle invading bladder cancer: do physicians in the United States practice evidence based medicine?
     Eur Urol. 2010;57:730-1.
     PubMed     Text format     Related articles   
     
     
     
     
109. STENZL A
     Words of wisdom. Re: sex and racial differences in bladder cancer presentation and mortality in the US.
     Eur Urol. 2010;57:729.
     PubMed     Text format     Related articles   
     
     
     
     
110. DRAGA RO , Grimbergen MC, Kok ET, Jonges TN, et al
     Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guerin immunotherapy and mitomycin C intravesical therapy.
     Eur Urol. 2010;57:655-60.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
111. DEGRAFF DJ
     Novel use of a combined artificial intelligence approach to identify patients with noninvasive urothelial cell carcinoma of the urinary bladder who are at greatest risk for progression to muscle-invasive disease: a step forward.
     Eur Urol. 2010;57:407-8.
     PubMed     Text format     Related articles   
     
     
     
     February 2010
112. LAWRENTSCHUK N , Colombo R, Hakenberg OW, Lerner SP, et al
     Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer.
     Eur Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. BRAUSI MA
     Words of wisdom. Re: open to debate. The motion: perioperative chemotherapy in muscle invasive bladder cancer improves survival.
     Eur Urol. 2010;57:354-5.
     PubMed     Text format     Related articles   
     
     
     
     
114. HAKENBERG OW
     Moving towards evidence-based surgery.
     Eur Urol. 2010;57:202-3.
     PubMed     Text format     Related articles   
     
     
     
     
115. SCHUMACHER MC , Holmang S, Davidsson T, Friedrich B, et al
     Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study.
     Eur Urol. 2010;57:293-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. HERR HW
     Extent of pelvic lymph node dissection during radical cystectomy: where and why!
     Eur Urol. 2010;57:212-3.
     PubMed     Text format     Related articles   
     
     
     
     
117. ROTH B , Wissmeyer MP, Zehnder P, Birkhauser FD, et al
     A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder.
     Eur Urol. 2010;57:205-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. FRITSCHE HM , Burger M, Svatek RS, Jeldres C, et al
     Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
     Eur Urol. 2010;57:300-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. THALMANN G
     Editorial comment on: characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
     Eur Urol. 2010;57:309.
     PubMed     Text format     Related articles   
     
     
     
     
120. GAKIS G , Stenzl A
     Editorial comment on: a comparison of postoperative complications in open versus robotic cystectomy.
     Eur Urol. 2010;57:281-2.
     PubMed     Text format     Related articles   
     
     
     
     
121. NG CK , Kauffman EC, Lee MM, Otto BJ, et al
     A comparison of postoperative complications in open versus robotic cystectomy.
     Eur Urol. 2010;57:274-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
122. DALBAGNI G
     Reply to Matthew Bultitude and Tim O'Brien's Letter to the Editor Re: Guido Dalbagni, Kinjal Vora, Matthew Kaag, et al. Clinical Outcome in a Contemporary Series of Restaged Patients with Clinical T1 Bladder Cancer. Eur Urol 2009;56:903-10.
     Eur Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
123. WITJES JA , Redorta JP, Jacqmin D, Sofras F, et al
     Hexaminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-Up of Patients with Non-Muscle-Invasive Bladder Cancer: Review of the Evidence and Recommendations.
     Eur Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. TILKI D , Reich O, Karakiewicz PI, Novara G, et al
     Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome.
     Eur Urol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. BULTITUDE M , O'Brien T
     Re: Guido Dalbagni, Kinjal Vora, Matthew Kaag, et al. Clinical Outcome in a Contemporary Series of Restaged Patients with Clinical T1 Bladder Cancer. Eur Urol 2009;56:903-10.
     Eur Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
126. CAI T , Bartoletti R
     Re: Guido Dalbagni, Kinjal Vora, Matthew Kaag, et al. Clinical Outcome in a Contemporary Series of Restaged Patients with Clinical T1 Bladder Cancer. Eur Urol 2009;56:903-10.
     Eur Urol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
127. BABJUK M
     What is the optimal treatment strategy for T1 bladder tumors?
     Eur Urol. 2010;57:32-4.
     PubMed     Text format     Related articles   
     
     
     
     
128. CHIN JL
     In search of the perfect crystal ball for Ta urothelial cancer.
     Eur Urol. 2010;57:21-2.
     PubMed     Text format     Related articles   
     
     
     
     
129. GHAZI A , Zimmermann R, Al-Bodour A, Shefler A, et al
     Optimizing the approach for lymph node dissection during laparoscopic radical cystectomy.
     Eur Urol. 2010;57:71-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: